SAT-382 Glucocorticoid Tapering in Monthly 1-mg Decrements Does Not Result in Clinically Manifest Adrenal Insufficiency in Patients with Rheumatoid Arthritis: Learnings from the Phase 3/4 SEMIRA Study

Introduction: Systemic glucocorticoids (GCs) are used to treat serious inflammatory diseases but are associated with adverse events. Guidelines recommend tapering GCs to the lowest possible dose and discontinuing as soon as possible. Physicians have concerns that reductions, even from low doses, may...

Descripción completa

Detalles Bibliográficos
Autores principales: Buttgereit, Frank, Nebesky, J. Michael, Burmester, Gerd, Hochberg, Marc, Bernasconi, Corrado, John, Markus, Donath, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Adrenal
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552170/
http://dx.doi.org/10.1210/js.2019-SAT-382

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552170/
http://dx.doi.org/10.1210/js.2019-SAT-382

Ejemplares similares